These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
490 related articles for article (PubMed ID: 25524244)
21. The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013. Golijanin B; Pereira J; Mueller-Leonhard C; Golijanin D; Amin A; Mega A; Boorjian SA; Thompson RH; Leibovich BC; Gershman B Urol Oncol; 2019 Dec; 37(12):932-940. PubMed ID: 31570248 [TBL] [Abstract][Full Text] [Related]
22. Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases. Giberti C; Oneto F; Martorana G; Rovida S; Carmignani G Eur Urol; 1997; 31(1):40-8. PubMed ID: 9032533 [TBL] [Abstract][Full Text] [Related]
23. Impact of lymph node invasion and sarcomatoid differentiation on the survival of patients with locally advanced renal cell carcinoma. Rodríguez-Covarrubias F; Castillejos-Molina R; Sotomayor M; Méndez-Probst CE; Gómez-Alvarado MO; Uribe-Uribe N; Gabilondo F; Feria-Bernal G Urol Int; 2010; 85(1):23-9. PubMed ID: 20693824 [TBL] [Abstract][Full Text] [Related]
24. [The indications for adrenalectomy in the surgical treatment of renal-cell cancer]. Serniak IuP Urol Nefrol (Mosk); 1997; (6):40-3. PubMed ID: 9461788 [TBL] [Abstract][Full Text] [Related]
25. Management of the adrenal gland during partial nephrectomy. Lane BR; Tiong HY; Campbell SC; Fergany AF; Weight CJ; Larson BT; Novick AC; Flechner SM J Urol; 2009 Jun; 181(6):2430-6; discussion 2436-7. PubMed ID: 19371896 [TBL] [Abstract][Full Text] [Related]
26. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma. Van Poppel H; Vandendriessche H; Boel K; Mertens V; Goethuys H; Haustermans K; Van Damme B; Baert L J Urol; 1997 Jul; 158(1):45-9. PubMed ID: 9186320 [TBL] [Abstract][Full Text] [Related]
27. Renal cell carcinoma with extension of tumor thrombus into the vena cava: surgical strategy and prognosis. Tsuji Y; Goto A; Hara I; Ataka K; Yamashita C; Okita Y; Kamidono S J Vasc Surg; 2001 Apr; 33(4):789-96. PubMed ID: 11296333 [TBL] [Abstract][Full Text] [Related]
28. Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience. Chen X; Li S; Xu Z; Wang K; Fu D; Liu Q; Wang X; Wu B World J Surg Oncol; 2015 Feb; 13():14. PubMed ID: 25650039 [TBL] [Abstract][Full Text] [Related]
29. Adrenal sparing surgery during radical nephrectomy in patients with renal cell cancer: a new algorithm. Paul R; Mordhorst J; Busch R; Leyh H; Hartung R J Urol; 2001 Jul; 166(1):59-62. PubMed ID: 11435823 [TBL] [Abstract][Full Text] [Related]
30. Is ipsilateral adrenalectomy a necessary component of radical nephrectomy? Shalev M; Cipolla B; Guille F; Staerman F; Lobel B J Urol; 1995 May; 153(5):1415-7. PubMed ID: 7714954 [TBL] [Abstract][Full Text] [Related]
31. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342 [TBL] [Abstract][Full Text] [Related]
32. Ipsilateral adrenalectomy at the time of radical nephrectomy impacts overall survival. Yap SA; Alibhai SM; Abouassaly R; Timilshina N; Margel D; Finelli A BJU Int; 2013 Mar; 111(3 Pt B):E54-8. PubMed ID: 23039377 [TBL] [Abstract][Full Text] [Related]
33. Cytokine therapy response as a selection criterion for cytoreductive nephrectomy in metastatic renal clear-cell carcinoma of intermediate prognosis. Results and conclusions from a combined analysis. Bex A; Haanen JB; Vyth-Dreese FA; Horenblas S; de Gast GC Urol Int; 2008; 80(4):367-71. PubMed ID: 18587246 [TBL] [Abstract][Full Text] [Related]
34. Reconsidering the necessity of ipsilateral adrenalectomy during radical nephrectomy for renal cell carcinoma. Leibovitch I; Raviv G; Mor Y; Nativ O; Goldwasser B Urology; 1995 Sep; 46(3):316-20. PubMed ID: 7660505 [TBL] [Abstract][Full Text] [Related]
35. The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma. Capitanio U; Matloob R; Suardi N; Abdollah F; Castiglione F; Di Trapani D; Russo A; Briganti A; Carenzi C; Salonia A; Montorsi F; Rigatti P; Bertini R Urologia; 2012; 79(2):109-15. PubMed ID: 22610843 [TBL] [Abstract][Full Text] [Related]
36. The role of surgery in the treatment of clinically isolated adrenal metastasis. Kim SH; Brennan MF; Russo P; Burt ME; Coit DG Cancer; 1998 Jan; 82(2):389-94. PubMed ID: 9445197 [TBL] [Abstract][Full Text] [Related]
37. Impact of clinicopathological parameters in patients treated for renal cell carcinoma. Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783 [TBL] [Abstract][Full Text] [Related]
38. [Current surgical aspects of renal cell carcinoma]. Zigeuner R; Pummer K Wien Med Wochenschr; 2009; 159(21-22):535-42. PubMed ID: 19997839 [TBL] [Abstract][Full Text] [Related]
39. Adrenal metastases in 1635 patients with renal cell carcinoma: outcome and indication for adrenalectomy. Siemer S; Lehmann J; Kamradt J; Loch T; Remberger K; Humke U; Ziegler M; Stöckle M J Urol; 2004 Jun; 171(6 Pt 1):2155-9; discussion 2159. PubMed ID: 15126776 [TBL] [Abstract][Full Text] [Related]
40. 10-year oncologic outcomes after laparoscopic and open partial nephrectomy. Lane BR; Campbell SC; Gill IS J Urol; 2013 Jul; 190(1):44-9. PubMed ID: 23306087 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]